Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$4.29 - $5.97 $330,261 - $459,594
-76,984 Reduced 69.24%
34,204 $154,000
Q4 2023

Feb 07, 2024

BUY
$3.91 - $5.93 $71,228 - $108,026
18,217 Added 19.59%
111,188 $634,000
Q3 2023

Nov 02, 2023

BUY
$4.6 - $7.95 $94,070 - $162,577
20,450 Added 28.2%
92,971 $427,000
Q2 2023

Aug 07, 2023

BUY
$5.66 - $7.59 $138,517 - $185,750
24,473 Added 50.93%
72,521 $468,000
Q1 2023

May 09, 2023

SELL
$7.31 - $11.18 $7,185 - $10,989
-983 Reduced 2.0%
48,048 $362,000
Q4 2022

Feb 09, 2023

BUY
$9.48 - $14.52 $226,628 - $347,115
23,906 Added 95.15%
49,031 $496,000
Q3 2022

Nov 09, 2022

BUY
$9.2 - $13.68 $48,042 - $71,436
5,222 Added 26.24%
25,125 $248,000
Q2 2022

Aug 10, 2022

BUY
$5.72 - $10.65 $113,845 - $211,966
19,903 New
19,903 $212,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.